Skip to main content
. 2012 Nov 15;23(22):4383–4392. doi: 10.1091/mbc.E12-05-0365

FIGURE 9:

FIGURE 9:

NMDA treatment reduces the association between CTTNBP2 and striatin (STN). Cultured hippocampal neurons were treated with 100 μM NMDA for 15 min and subjected to immunoprecipitation using CTTNBP2 and striatin antibody. Nonimmune IgG was used as a negative control. The associations of striatin with CTTNBP2 were analyzed by immunoblotting. The asterisks indicate unknown proteins recognized by CTTNBP2 antibody, which may be either degraded CTTNBP2 or cross-reactive protein species.